Psoriasis affects more than 100 million people worldwide according to the World Health Organization. The number of triggers and associated comorbidities make this immune disorder difficult for patients to manage. As part of Psoriasis Awareness Month, we’re highlighting how UBC’s experts are helping advance treatment options while also focusing on the needs of individual patients.
Understanding risk factors for medication non-adherence is becoming increasingly important in oncology. Patient-reported outcome (PRO) instruments may provide valuable insight on barriers to medication adherence in the real world. A study presented at ISPOR sought to identify and describe key patient-reported risk factors for non-adherence measured in observational studies evaluating adherence with OAAs.
Patient-centric medicine is not a passing fad. New technology trends, healthcare laws, and diverse therapeutic options are converging to provide patients even more opportunities to be proactively engaged in their health journeys.
UBC’s patient engagement experts will share tools that allow for understanding and addressing patients’ needs and concerns in a free webinar on Thursday, November 20th at 3 p.m. EST.
Costs to our healthcare system attributed to non-adherence to treatment continue to climb each year. Rather than treating the patient as a passive recipient of adherence messaging, it’s time to actively engage the patient in effective strategies which improve adherence and health outcomes.
Patients taking oral oncology medications face a combination of challenges that can make it difficult to remain adherent to their medications. Research shows that Accredo can help.
Specialty patients often face complex and costly treatments for their therapies. Nonadherence among these patients can lead to expensive and dangerous adverse health effects. Research shows that keeping one organ transplant patient adherent to anti-rejection therapy can prevent more than $19,190 in wasteful medical costs per year.